Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
StoneBridge54's Profile
Displaying 1-36 of 36 result(s).
TOMDF Todos Med Ltd.
05/28/2022 10:19:31 PM
Gerald, Dr Arad and and Todos perso
TOMDF Todos Med Ltd.
05/10/2022 10:17:05 PM
Petrosino now on Stocktwits, postin
TOMDF Todos Med Ltd.
05/09/2022 5:09:02 PM
It’s one thing for Petrosino (and
TOMDF Todos Med Ltd.
05/08/2022 11:34:55 AM
It took about 2 months to get the d
TOMDF Todos Med Ltd.
05/06/2022 10:05:08 PM
It was a good for GC to release the
TOMDF Todos Med Ltd.
05/06/2022 6:43:55 PM
Gerald Tweeted the valuation put on (1)
TOMDF Todos Med Ltd.
04/24/2022 9:37:58 AM
Twitter: Author Alisa Lynn Valdes - (2)
TOMDF Todos Med Ltd.
04/13/2022 8:04:24 PM
Psycho Ward let JP out, and he’s
TOMDF Todos Med Ltd.
04/07/2022 9:39:14 PM
Got a post up on iLie, before but g
TOMDF Todos Med Ltd.
04/06/2022 10:38:43 AM
Appreciate it. They all but banned
TOMDF Todos Med Ltd.
04/06/2022 12:04:41 AM
Can anyone here tear JP a new ass o
TOMDF Todos Med Ltd.
04/05/2022 10:45:08 PM
JP thinks people care about him get
TOMDF Todos Med Ltd.
04/05/2022 6:42:20 PM
Unbelievable. Over on iLie, some ar
TOMDF Todos Med Ltd.
04/04/2022 10:04:45 AM
https://investor.todosmedical.com/
TOMDF Todos Med Ltd.
03/28/2022 11:43:16 PM
You guys are the experts. Tell us w
TOMDF Todos Med Ltd.
03/28/2022 3:10:46 PM
Really like the Influencer approach
TOMDF Todos Med Ltd.
03/22/2022 10:15:08 PM
You guys have this wrapped tighter
TOMDF Todos Med Ltd.
03/22/2022 1:26:26 AM
Yes, I do think some of her persona
TOMDF Todos Med Ltd.
03/22/2022 1:10:41 AM
I was reading about her before I in
TOMDF Todos Med Ltd.
03/21/2022 10:41:35 PM
So the deal excludes her personally
TOMDF Todos Med Ltd.
03/21/2022 6:07:15 PM
Article from 2008, on Arad. 3C and
TOMDF Todos Med Ltd.
03/21/2022 5:50:41 PM
https://patents.justia.com/invento
TOMDF Todos Med Ltd.
03/21/2022 2:38:19 PM
Great info, thank you.
TOMDF Todos Med Ltd.
03/19/2022 2:21:45 PM
Yea, new Twitter name. I’ll go ba
TOMDF Todos Med Ltd.
03/19/2022 11:24:19 AM
“Leave it up to people to see wha (1)
TOMDF Todos Med Ltd.
03/19/2022 11:18:21 AM
Typically you would Censor my post, (1)
TOMDF Todos Med Ltd.
03/19/2022 11:01:43 AM
I appreciate THIS REPLY, as I donâ€
TOMDF Todos Med Ltd.
03/18/2022 10:01:40 PM
You guys are pretty good at trackin
TOMDF Todos Med Ltd.
03/15/2022 1:19:59 AM
Point well made. My apologies to Gr (1)
TOMDF Todos Med Ltd.
03/14/2022 6:02:46 PM
What is Todos reporting Thursday. E
TOMDF Todos Med Ltd.
03/14/2022 3:03:35 PM
In IHub, GreeseMonkey resigned as a
TOMDF Todos Med Ltd.
03/14/2022 2:53:29 PM
Refreshing to hear JPekkerhead gett (1)
TOMDF Todos Med Ltd.
03/12/2022 10:41:54 PM
Best post I’ve read in a long tim
TOMDF Todos Med Ltd.
03/12/2022 5:49:04 PM
Great Post. They sure are people wi (1)
TOMDF Todos Med Ltd.
03/11/2022 10:35:30 PM
I tweeted Santana back in January, (3)
TOMDF Todos Med Ltd.
03/11/2022 5:56:00 PM
JPetroInc got me Deleted off of Inv

Recent Articles

  • Joe Rogan Challenges the Ailments of the Insurance Industry
  • Tesla's Robotaxi Dreams Ignite Stock Prices Amid Hype
  • Arbor Realty Trust to Host Earnings Call for Q2 2025 Results
  • J.M. Smucker's Financial Woes and Investor Concerns Unveiled
  • Portage Biotech's Fiscal Year 2025 Financial Insights Revealed
  • Investors in Replimune Group, Inc. Can Join Class Action Today
  • Opportunity for Luminar Technologies, Inc. Investors to Join Lawsuit
  • Treatment.com AI Secures C$3 Million in Innovative Financing
  • Investors In Reckitt Benckiser Group PLC May Pursue Class Action
  • Silvercrest Asset Management's Upcoming Earnings Call Details
  • Exploring BlackRock's Stock Growth Over a Decade: Insights
  • NurExone Biologic Approved as Finalist for Prestigious Award
  • Silvercrest Asset Management Prepares for Next Earnings Call
  • Celcuity’s Upcoming Conference Call on PIK3CA Trial Results
  • Iradimed Corporation Schedules Q2 2025 Financial Update Call
  • Recognify Life Sciences Shares Phase 2b Trial Findings for Inidascamine
  • Celcuity Prepares for Groundbreaking VIKTORIA-1 Results Reveal
  • IRADIMED CORPORATION Set to Share Q2 2025 Financial Insights
  • Understanding the P/E Ratio for Otis Worldwide's Stock
  • Analyzing FedEx's Recent Options Movements and Trends
  • Understanding Options Trends of Lowe's Companies for Investors
  • Exploring Options Trends and Insights for Palo Alto Networks
  • Economic Shifts and Corporate Performance Influence Markets
  • TSA Invites Innovations for Improved Airport Security Measures
  • Pacific West Bancorp Financial Performance Highlights
  • Pacific West Bancorp Reports Noteworthy Q2 Financial Achievements
  • Elemental: Reforged - The Return to Fantasy Strategy Gaming
  • ASI Show Chicago 2025 Welcomes Thousands of Promotional Experts
  • Flagstar Financial Announces Latest Dividend Payouts for Investors
  • Velo3D, Inc. Implements Strategic Reverse Stock Split Plan
  • Peoples Financial Services Corp. Announces Q3 2025 Dividend Plans
  • Legal Analysis: Investigating Barnes & Noble Education, Inc.
  • Impact of Recent Executive Order on Private Prison Stocks
  • Analyzing the Surge in Ford Motor's Short Interest Figures
  • Understanding Investor Sentiment Towards Valvoline's Future
  • Investor Sentiment and Trends Surrounding S&P Global Stocks
  • Exploring Opportunities for Dow Inc. Amid Market Dynamics
  • ARK Innovation ETF Thrives Amidst Changing Market Dynamics
  • Jones Walker Expands Tax Practice with New Partner in Minnesota
  • Significant Conference on Austin Tice's Ongoing Case
  • Formula GT: Revolutionizing Motorsport with Hypercar Innovations
  • Transforming Payments: MicroBitcoin (MBC) Now on Coinstore
  • Hubbell Incorporated Declares Robust Dividend for Investors
  • VCI Global Unveils SecureGPUâ„¢ - Innovative AI Compute Solution
  • Boulevard Kitchen & Oyster Bar Invites You to Seafood Delight
  • Investors Urged to Act on Neogen Corp Class Action Deadline
  • Update on Investor Class Action for RxSight, Inc. Stockholders
  • Legal Proceedings for Capricor Therapeutics Investors Unveiled
  • Innovative ELIXIR MDâ„¢ Device Launches in Mexico for Aesthetic Solutions
  • JD Martin Welcomes Adam Hayes as New Regional VP
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site